Page last updated: 2024-08-23

butaclamol and Basal Ganglia Diseases

butaclamol has been researched along with Basal Ganglia Diseases in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	2 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Allen, RM	1
Clark, ML; Costiloe, JP; Fulkerson, FG; Paredes, A; Wood, F	1

Reviews

1 review(s) available for butaclamol and Basal Ganglia Diseases

Article	Year
Role of amantadine in the management of neuroleptic-induced extrapyramidal syndromes: overview and pharmacology. Clinical neuropharmacology, 1983, Volume: 6 Suppl 1 Topics: Amantadine; Animals; Antipsychotic Agents; Apomorphine; Basal Ganglia Diseases; Binding, Competitive; Butaclamol; Humans; Kinetics; Spiperone	1983

Trials

1 trial(s) available for butaclamol and Basal Ganglia Diseases

Article	Year
Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design. Diseases of the nervous system, 1977, Volume: 38, Issue:11 Topics: Adolescent; Adult; Basal Ganglia Diseases; Butaclamol; Chronic Disease; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Schizophrenia; Time Factors	1977

Article

Year

Butaclamol in newly admitted chronic schizophrenic patients: a modified fixed-dose dose-range design.

Diseases of the nervous system, 1977, Volume: 38, Issue:11

Topics: Adolescent; Adult; Basal Ganglia Diseases; Butaclamol; Chronic Disease; Dibenzocycloheptenes; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Female; Hospitalization; Humans; Hypnotics and Sedatives; Male; Middle Aged; Schizophrenia; Time Factors

1977